{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:24:42Z","timestamp":1783106682228,"version":"3.54.6"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Peking University People\u2019s Hospital Research and Development Funds","award":["RDGS2023-06"],"award-info":[{"award-number":["RDGS2023-06"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82071813"],"award-info":[{"award-number":["82071813"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-026-03806-w","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T06:37:27Z","timestamp":1775457447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["IL-2: a promising topical treatment for Sj\u00f6gren\u2019s disease-related dry eye disease"],"prefix":"10.1186","volume":"28","author":[{"given":"Bo","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junru","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"3806_CR1","doi-asserted-by":"publisher","first-page":"8824","DOI":"10.3390\/ijms26188824","volume":"26","author":"M Soyfoo","year":"2025","unstructured":"Soyfoo M, Motulsky E, Sarrand J. Keratoconjunctivitis sicca in Sj\u00f6gren disease: diagnostic challenges and therapeutic advances. Int J Mol Sci. 2025;26:8824. https:\/\/doi.org\/10.3390\/ijms26188824.","journal-title":"Int J Mol Sci"},{"key":"3806_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.clim.2019.04.009","volume":"203","author":"FB Vivino","year":"2019","unstructured":"Vivino FB, Bunya VY, Massaro-Giordano G, Johr CR, Giattino SL, Schorpion A, et al. Sjogren\u2019s syndrome: an update on disease pathogenesis, clinical manifestations and treatment. Clin Immunol. 2019;203:81\u2013121. https:\/\/doi.org\/10.1016\/j.clim.2019.04.009.","journal-title":"Clin Immunol"},{"key":"3806_CR3","doi-asserted-by":"publisher","first-page":"994","DOI":"10.3390\/ph18070994","volume":"18","author":"J Betz","year":"2025","unstructured":"Betz J, Galor A. Navigating the dry eye therapeutic puzzle: a mechanism-based overview of current treatments. Pharmaceuticals. 2025;18:994. https:\/\/doi.org\/10.3390\/ph18070994.","journal-title":"Pharmaceuticals"},{"key":"3806_CR4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41584-024-01135-3","volume":"20","author":"C Baldini","year":"2024","unstructured":"Baldini C, Fulvio G, La Rocca G, Ferro F. Update on the pathophysiology and treatment of primary sj\u00f6gren syndrome. Nat Rev Rheumatol. 2024;20:473\u201391. https:\/\/doi.org\/10.1038\/s41584-024-01135-3.","journal-title":"Nat Rev Rheumatol"},{"key":"3806_CR5","doi-asserted-by":"publisher","first-page":"11820","DOI":"10.3390\/ijms222111820","volume":"22","author":"Y Ogawa","year":"2021","unstructured":"Ogawa Y, Takeuchi T, Tsubota K. Autoimmune epithelitis and chronic inflammation in Sj\u00f6gren\u2019s syndrome-related dry eye disease. Int J Mol Sci. 2021;22:11820. https:\/\/doi.org\/10.3390\/ijms222111820.","journal-title":"Int J Mol Sci"},{"key":"3806_CR6","doi-asserted-by":"publisher","first-page":"7171","DOI":"10.3390\/ijms25137171","volume":"25","author":"DY Honing","year":"2024","unstructured":"Honing DY, Luiten RM, Matos TR. Regulatory T cell dysfunction in autoimmune diseases. Int J Mol Sci. 2024;25:7171. https:\/\/doi.org\/10.3390\/ijms25137171.","journal-title":"Int J Mol Sci"},{"key":"3806_CR7","doi-asserted-by":"publisher","first-page":"1468469","DOI":"10.3389\/fimmu.2024.1468469","volume":"15","author":"Q Meng","year":"2024","unstructured":"Meng Q, Ma J, Cui J, Gu Y, Shan Y. Subpopulation dynamics of T and B lymphocytes in Sj\u00f6gren\u2019s syndrome: implications for disease activity and treatment. Front Immunol. 2024;15:1468469. https:\/\/doi.org\/10.3389\/fimmu.2024.1468469.","journal-title":"Front Immunol"},{"key":"3806_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/ICL.0000000000000042","volume":"40","author":"Y Wei","year":"2014","unstructured":"Wei Y, Asbell PA. The core mechanism of dry eye disease (DED) is inflammation. Eye Contact Lens. 2014;40:248\u201356. https:\/\/doi.org\/10.1097\/ICL.0000000000000042.","journal-title":"Eye Contact Lens"},{"key":"3806_CR9","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jtos.2019.03.005","volume":"17","author":"H Liang","year":"2019","unstructured":"Liang H, Kessal K, Rabut G, Daull P, Garrigue JS, Melik Parsadaniantz S, et al. Correlation of clinical symptoms and signs with conjunctival gene expression in primary sj\u00f6gren syndrome dry eye patients. Ocul Surf. 2019;17:516\u201325. https:\/\/doi.org\/10.1016\/j.jtos.2019.03.005.","journal-title":"Ocul Surf"},{"key":"3806_CR10","doi-asserted-by":"publisher","first-page":"7319","DOI":"10.1038\/s41598-019-43714-5","volume":"9","author":"X Chen","year":"2019","unstructured":"Chen X, Aqrawi LA, Utheim TP, Tashbayev B, Utheim \u00d8A, Reppe S, et al. Elevated cytokine levels in tears and saliva of patients with primary sj\u00f6gren\u2019s syndrome correlate with clinical ocular and oral manifestations. Sci Rep. 2019;9:7319. https:\/\/doi.org\/10.1038\/s41598-019-43714-5.","journal-title":"Sci Rep"},{"key":"3806_CR11","doi-asserted-by":"publisher","first-page":"109057","DOI":"10.1016\/j.exer.2022.109057","volume":"219","author":"M Blanco-V\u00e1zquez","year":"2022","unstructured":"Blanco-V\u00e1zquez M, V\u00e1zquez A, Fern\u00e1ndez I, Novo-Diez A, Mart\u00ednez-Plaza E, Garc\u00eda-V\u00e1zquez C, et al. Inflammation-related molecules in tears of patients with chronic ocular pain and dry eye disease. Exp Eye Res. 2022;219:109057. https:\/\/doi.org\/10.1016\/j.exer.2022.109057.","journal-title":"Exp Eye Res"},{"key":"3806_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.cyto.2018.05.013","volume":"110","author":"L Tong","year":"2018","unstructured":"Tong L, Wong TY, Cheng Y. Level of tear cytokines in population-level participants and correlation with clinical features. Cytokine. 2018;110:452\u20138. https:\/\/doi.org\/10.1016\/j.cyto.2018.05.013.","journal-title":"Cytokine"},{"key":"3806_CR13","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.3390\/ijms21093111","volume":"21","author":"M Roda","year":"2020","unstructured":"Roda M, Corazza I, Bacchi Reggiani ML, Pellegrini M, Taroni L, Giannaccare G, et al. Dry eye disease and tear cytokine levels\u2014a meta-analysis. Int J Mol Sci. 2020;21:3111. https:\/\/doi.org\/10.3390\/ijms21093111.","journal-title":"Int J Mol Sci"},{"key":"3806_CR14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/ICU.0000000000000768","volume":"32","author":"R Mittal","year":"2021","unstructured":"Mittal R, Patel S, Galor A. Alternative therapies for dry eye disease. Curr Opin Ophthalmol. 2021;32:348\u201361. https:\/\/doi.org\/10.1097\/ICU.0000000000000768.","journal-title":"Curr Opin Ophthalmol"},{"key":"3806_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ajo.2025.05.039","volume":"279","author":"L Jones","year":"2025","unstructured":"Jones L, Craig JP, Markoulli M, Karpecki P, Akpek EK, Basu S, et al. TFOS DEWS III: management and therapy. Am J Ophthalmol. 2025;279:289\u2013386. https:\/\/doi.org\/10.1016\/j.ajo.2025.05.039.","journal-title":"Am J Ophthalmol"},{"key":"3806_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/annrheumdis-2019-215396","volume":"79","author":"J He","year":"2020","unstructured":"He J, Zhang R, Shao M, Zhao X, Miao M, Chen J, et al. Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2020;79:141\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215396.","journal-title":"Ann Rheum Dis"},{"key":"3806_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41392-022-00887-2","volume":"7","author":"X Zhang","year":"2022","unstructured":"Zhang X, Miao M, Zhang R, Liu X, Zhao X, Shao M, et al. Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial. Signal Transduct Target Ther. 2022;7:67. https:\/\/doi.org\/10.1038\/s41392-022-00887-2.","journal-title":"Signal Transduct Target Ther"},{"key":"3806_CR18","doi-asserted-by":"publisher","first-page":"e2241451","DOI":"10.1001\/jamanetworkopen.2022.41451","volume":"5","author":"J He","year":"2022","unstructured":"He J, Chen J, Miao M, Zhang R, Cheng G, Wang Y, et al. Efficacy and safety of low-dose interleukin 2 for primary sj\u00f6gren syndrome: a randomized clinical trial. JAMA Netw Open. 2022;5:e2241451. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.41451.","journal-title":"JAMA Netw Open"},{"key":"3806_CR19","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1136\/annrheumdis-2018-213036","volume":"77","author":"M Miao","year":"2018","unstructured":"Miao M, Hao Z, Guo Y, Zhang X, Zhang S, Luo J, et al. Short-term and low-dose IL-2 therapy restores the Th17\/treg balance in the peripheral blood of patients with primary sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2018;77:1838\u201340. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213036.","journal-title":"Ann Rheum Dis"},{"key":"3806_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41392-023-01350-6","volume":"8","author":"H Zhou","year":"2023","unstructured":"Zhou H, Zhao X, Zhang R, Miao M, Pei W, Li Z, et al. Low-dose IL-2 mitigates glucocorticoid-induced treg impairment and promotes improvement of SLE. Signal Transduct Target Ther. 2023;8:141. https:\/\/doi.org\/10.1038\/s41392-023-01350-6.","journal-title":"Signal Transduct Target Ther"},{"key":"3806_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13075-021-02535-6","volume":"23","author":"M Miao","year":"2021","unstructured":"Miao M, Xiao X, Tian J, Zhufeng Y, Feng R, Zhang R, et al. Therapeutic potential of targeting tfr\/tfh cell balance by low-dose-IL-2 in active SLE: a post hoc analysis from a double-blind RCT study. Arthritis Res Ther. 2021;23:167. https:\/\/doi.org\/10.1186\/s13075-021-02535-6.","journal-title":"Arthritis Res Ther"},{"key":"3806_CR22","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nm.4148","volume":"22","author":"J He","year":"2016","unstructured":"He J, Zhang X, Wei Y, Sun X, Chen Y, Deng J, et al. Low-dose interleukin-2 treatment selectively modulates CD4\u2009+\u2009T cell subsets in patients with systemic lupus erythematosus. Nat Med. 2016;22:991\u20133. https:\/\/doi.org\/10.1038\/nm.4148.","journal-title":"Nat Med"},{"key":"3806_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1167\/iovs.66.12.16","volume":"66","author":"CD Patil","year":"2025","unstructured":"Patil CD, Naqvi RA, Borase H, Valverde A, Naqvi AR, Shukla D. Antagonizing viral MicroRNAs reduces ocular HSV-1 pathogenesis and enhances mucosal immune homeostasis. Invest Ophthalmol Visual Sci. 2025;66:16\u201330. https:\/\/doi.org\/10.1167\/iovs.66.12.16.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"3806_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jtos.2023.09.004","volume":"30","author":"F Bonelli","year":"2023","unstructured":"Bonelli F, Demirsoy I, Lasagni Vitar RM, Fonteyne P, Ferrari G. Topical formulations of aprepitant are safe and effective in relieving pain and inflammation, and drive neural regeneration. Ocul Surf. 2023;30:92\u2013103. https:\/\/doi.org\/10.1016\/j.jtos.2023.09.004.","journal-title":"Ocul Surf"},{"key":"3806_CR25","doi-asserted-by":"publisher","first-page":"118625","DOI":"10.1016\/j.biopha.2025.118625","volume":"192","author":"T Migeon","year":"2025","unstructured":"Migeon T, Cordovilla A, Potey A, Delarasse C, Hourcade T, Reboussin E, et al. TRPA1 inhibition reduces ocular pain and corneal neurogenic inflammation in a mouse model of dry eye disease. Biomed Pharmacother. 2025;192:118625. https:\/\/doi.org\/10.1016\/j.biopha.2025.118625.","journal-title":"Biomed Pharmacother"},{"key":"3806_CR26","doi-asserted-by":"publisher","first-page":"117544","DOI":"10.1016\/j.jep.2023.117544","volume":"321","author":"P Liu","year":"2024","unstructured":"Liu P, Jiang P, Yu Y, Tan K, Qin G, Liu T, et al. Modified danzhi xiaoyao powder (MDXP) improves the corneal damage in dry eye disease (DED) mice through phagocytosis. J Ethnopharmacol. 2024;321:117544. https:\/\/doi.org\/10.1016\/j.jep.2023.117544.","journal-title":"J Ethnopharmacol"},{"key":"3806_CR27","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41577-018-0046-y","volume":"18","author":"R Spolski","year":"2018","unstructured":"Spolski R, Li P, Leonard WJ. Biology and regulation of IL-2: from molecular mechanisms to human therapy. Nat Rev Immunol. 2018;18:648\u201359. https:\/\/doi.org\/10.1038\/s41577-018-0046-y.","journal-title":"Nat Rev Immunol"},{"key":"3806_CR28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nri3156","volume":"12","author":"O Boyman","year":"2012","unstructured":"Boyman O, Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol. 2012;12:180\u201390. https:\/\/doi.org\/10.1038\/nri3156.","journal-title":"Nat Rev Immunol"},{"key":"3806_CR29","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ajo.2025.05.033","volume":"279","author":"JS Wolffsohn","year":"2025","unstructured":"Wolffsohn JS, Ben\u00edtez-Del-Castillo JM, Loya-Garcia D, Inomata T, Iyer G, Liang L, et al. TFOS DEWS III: diagnostic methodology. Am J Ophthalmol. 2025;279:387\u2013450. https:\/\/doi.org\/10.1016\/j.ajo.2025.05.033.","journal-title":"Am J Ophthalmol"},{"key":"3806_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/BF00918149","volume":"12","author":"DI Yannopoulos","year":"1992","unstructured":"Yannopoulos DI, Roncin S, Lamour A, Pennec YL, Moutsopoulos HM, Youinou P. Conjunctival epithelial cells from patients with sj\u00f6gren\u2019s syndrome inappropriately express major histocompatibility complex molecules, La(SSB) antigen, and heat-shock proteins. J ClinImmunol. 1992;12:259\u201365. https:\/\/doi.org\/10.1007\/BF00918149.","journal-title":"J ClinImmunol"},{"key":"3806_CR31","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.3390\/ijms19092760","volume":"19","author":"SC Pflugfelder","year":"2018","unstructured":"Pflugfelder SC, Bian F, Gumus K, Farley W, Stern ME, De Paiva CS. Severity of Sj\u00f6gren\u2019s syndrome keratoconjunctivitis sicca increases with increased percentage of conjunctival antigen-presenting cells. Int J Mol Sci. 2018;19:2760. https:\/\/doi.org\/10.3390\/ijms19092760.","journal-title":"Int J Mol Sci"},{"key":"3806_CR32","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/aos.12801","volume":"93","author":"P Stenwall","year":"2015","unstructured":"Stenwall P, Bergstr\u00f6m M, Seiron P, Sellberg F, Olsson T, Knutson F, et al. Improving the anti-inflammatory effect of serum eye drops using allogeneic serum permissive for regulatory T cell induction. Acta Ophthalmol (Copenh). 2015;93:654\u20137. https:\/\/doi.org\/10.1111\/aos.12801.","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"3806_CR33","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jconrel.2017.05.007","volume":"258","author":"ML Ratay","year":"2017","unstructured":"Ratay ML, Glowacki AJ, Balmert SC, Acharya AP, Polat J, Andrews LP, et al. Treg-recruiting microspheres prevent inflammation in a murine model of dry eye disease. J Controlled Release. 2017;258:208\u201317. https:\/\/doi.org\/10.1016\/j.jconrel.2017.05.007.","journal-title":"J Controlled Release"},{"key":"3806_CR34","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1136\/annrheumdis-2015-207776","volume":"75","author":"C Von Spee-Mayer","year":"2016","unstructured":"Von Spee-Mayer C, Siegert E, Abdirama D, Rose A, Klaus A, Alexander T, et al. Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus. Ann Rheum Dis. 2016;75:1407\u201315. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207776.","journal-title":"Ann Rheum Dis"},{"key":"3806_CR35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/rheumatology\/kep357","volume":"49","author":"CS De Paiva","year":"2010","unstructured":"De Paiva CS, Hwang CS, Pitcher JD, Pangelinan SB, Rahimy E, Chen W, et al. Age-related T-cell cytokine profile parallels corneal disease severity in sj\u00f6gren\u2019s syndrome-like keratoconjunctivitis sicca in CD25KO mice. Rheumatol (oxf Engl). 2010;49:246\u201358. https:\/\/doi.org\/10.1093\/rheumatology\/kep357.","journal-title":"Rheumatol (oxf Engl)"},{"key":"3806_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/ICO.0000000000000721","volume":"35","author":"JF Meadows","year":"2016","unstructured":"Meadows JF, Dionne K, Nichols KK. Differential profiling of T-cell cytokines as measured by protein microarray across dry eye subgroups. Cornea. 2016;35:329\u201335. https:\/\/doi.org\/10.1097\/ICO.0000000000000721.","journal-title":"Cornea"},{"key":"3806_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41385-020-0289-3","volume":"14","author":"Y Chen","year":"2021","unstructured":"Chen Y, Shao C, Fan N-W, Nakao T, Amouzegar A, Chauhan SK, et al. The functions of IL-23 and IL-2 on driving autoimmune effector T-helper 17 cells into the memory pool in dry eye disease. Mucosal Immunol. 2021;14:177\u201386. https:\/\/doi.org\/10.1038\/s41385-020-0289-3.","journal-title":"Mucosal Immunol"},{"key":"3806_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1167\/iovs.66.4.66","volume":"66","author":"L Zhao","year":"2025","unstructured":"Zhao L, Li N, Shi X, Zhang J, Gao M, Wei Y, et al. Enhanced therapeutic effect of IL-10-ADSCs on rabbit autoimmune dacryoadenitis by suppressing T follicular helper cell responses via miR-142-5p\/RC3H1 axis. Invest Ophthalmol Visual Sci. 2025;66:66. https:\/\/doi.org\/10.1167\/iovs.66.4.66.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"3806_CR39","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.3892\/mmr.2014.2073","volume":"9","author":"B Li","year":"2014","unstructured":"Li B, Tian L, Diao Y, Li X, Zhao L, Wang X. Exogenous IL-10 induces corneal transplantation immune tolerance by a mechanism associated with the altered Th1\/Th2 cytokine ratio and the increased expression of TGF-\u03b2. Mol Med Rep. 2014;9:2245\u201350. https:\/\/doi.org\/10.3892\/mmr.2014.2073.","journal-title":"Mol Med Rep"},{"key":"3806_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ajpath.2015.09.012","volume":"186","author":"D Hos","year":"2016","unstructured":"Hos D, Bucher F, Regenfuss B, Dreisow M-L, Bock F, Heindl LM, et al. IL-10 indirectly regulates corneal lymphangiogenesis and resolution of inflammation via macrophages. Am J Pathol. 2016;186:159\u201371. https:\/\/doi.org\/10.1016\/j.ajpath.2015.09.012.","journal-title":"Am J Pathol"},{"key":"3806_CR41","doi-asserted-by":"publisher","first-page":"e0126277","DOI":"10.1371\/journal.pone.0126277","volume":"10","author":"L Niu","year":"2015","unstructured":"Niu L, Zhang S, Wu J, Chen L, Wang Y. Upregulation of NLRP3 inflammasome in the tears and ocular surface of dry eye patients. PLoS ONE. 2015;10:e0126277. https:\/\/doi.org\/10.1371\/journal.pone.0126277.","journal-title":"PLoS ONE"},{"key":"3806_CR42","doi-asserted-by":"publisher","first-page":"e010979","DOI":"10.1136\/bmjopen-2015-010979","volume":"6","author":"C Zhang","year":"2016","unstructured":"Zhang C, Xi L, Zhao S, Wei R, Huang Y, Yang R, et al. Interleukin-1\u03b2 and tumour necrosis factor-\u03b1 levels in conjunctiva of diabetic patients with symptomatic moderate dry eye: case\u2013control study. BMJ Open. 2016;6:e010979. https:\/\/doi.org\/10.1136\/bmjopen-2015-010979.","journal-title":"BMJ Open"},{"key":"3806_CR43","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3341\/kjo.2016.30.4.302","volume":"30","author":"W Choi","year":"2016","unstructured":"Choi W, Noh H, Yeo A, Jang H, Ahn HK, Song YJ, et al. The effect of TNF-\u03b1 blocker HL036337 and its best concentration to inhibit dry eye inflammation. Korean J Ophthalmol: KJO. 2016;30:302\u20138. https:\/\/doi.org\/10.3341\/kjo.2016.30.4.302.","journal-title":"Korean J Ophthalmol: KJO"},{"key":"3806_CR44","doi-asserted-by":"publisher","first-page":"7557","DOI":"10.1167\/iovs.12-11515","volume":"54","author":"YW Ji","year":"2013","unstructured":"Ji YW, Byun YJ, Choi W, Jeong E, Kim JS, Noh H, et al. Neutralization of ocular surface TNF-\u03b1 reduces ocular surface and lacrimal gland inflammation induced by In vivo dry eye. Investig Opthalmology Vis Sci. 2013;54:7557. https:\/\/doi.org\/10.1167\/iovs.12-11515.","journal-title":"Investig Opthalmology Vis Sci"},{"key":"3806_CR45","doi-asserted-by":"publisher","first-page":"DES192","DOI":"10.1167\/iovs.17-23651","volume":"59","author":"T Yamaguchi","year":"2018","unstructured":"Yamaguchi T. Inflammatory response in dry eye. Investig Opthalmology Vis Sci. 2018;59:DES192. https:\/\/doi.org\/10.1167\/iovs.17-23651.","journal-title":"Investig Opthalmology Vis Sci"},{"key":"3806_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1476-9255-6-31","volume":"6","author":"CS De Paiva","year":"2009","unstructured":"De Paiva CS, Yoon K-C, Pangelinan SB, Pham S, Puthenparambil LM, Chuang EY, et al. Cleavage of functional IL-2 receptor alpha chain (CD25) from murine corneal and conjunctival epithelia by MMP-9. J Inflamm (lond Engl). 2009;6:31. https:\/\/doi.org\/10.1186\/1476-9255-6-31.","journal-title":"J Inflamm (lond Engl)"},{"key":"3806_CR47","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/ACI.0000000000000841","volume":"22","author":"N Erdinest","year":"2022","unstructured":"Erdinest N, Pincovich S, London N, Solomon A. Neurostimulation for dry eye disease. Curr Opin Allergy Clin Immunol. 2022;22:328\u201334. https:\/\/doi.org\/10.1097\/ACI.0000000000000841.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"3806_CR48","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s12017-021-08656-0","volume":"23","author":"MC Borlongan","year":"2021","unstructured":"Borlongan MC, Kingsbury C, Salazar FE, Toledo ARL, Monroy GR, Sadanandan N, et al. IL-2\/IL-2R antibody complex enhances treg-induced neuroprotection by dampening TNF-\u03b1 inflammation in an In vitro stroke model. NeuroMol Med. 2021;23:540\u20138. https:\/\/doi.org\/10.1007\/s12017-021-08656-0.","journal-title":"NeuroMol Med"},{"key":"3806_CR49","doi-asserted-by":"publisher","first-page":"108442","DOI":"10.1016\/j.exer.2021.108442","volume":"204","author":"SA Esp\u00edrito-Santo","year":"2021","unstructured":"Esp\u00edrito-Santo SA, Nunes-Tavares N, Mendon\u00e7a HR, Serfaty CA, Sholl-Franco A, Campello-Costa P. Intravitreal interleukin-2 modifies retinal excitatory circuits and retinocollicular innervation. Exp Eye Res. 2021;204:108442. https:\/\/doi.org\/10.1016\/j.exer.2021.108442.","journal-title":"Exp Eye Res"},{"key":"3806_CR50","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.2147\/JPR.S550012","volume":"18","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Shen L, Huang Y. Low-dose IL-2 attenuates neuropathic pain via treg expansion in rats. J Pain Res. 2025;18:5011\u201322. https:\/\/doi.org\/10.2147\/JPR.S550012.","journal-title":"J Pain Res"},{"key":"3806_CR51","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.3390\/ijms19123821","volume":"19","author":"MA Stepp","year":"2018","unstructured":"Stepp MA, Pal-Ghosh S, Tadvalkar G, Williams AR, Pflugfelder SC, de Paiva CS. Reduced corneal innervation in the CD25 null model of sj\u00f6gren syndrome. Int J Mol Sci. 2018;19:3821. https:\/\/doi.org\/10.3390\/ijms19123821.","journal-title":"Int J Mol Sci"},{"key":"3806_CR52","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.it.2020.06.012","volume":"41","author":"M Vaeth","year":"2020","unstructured":"Vaeth M, Kahlfuss S, Feske S. CRAC channels and calcium signaling in T cell-mediated immunity. Trends Immunol. 2020;41:878\u2013901. https:\/\/doi.org\/10.1016\/j.it.2020.06.012.","journal-title":"Trends Immunol"},{"key":"3806_CR53","doi-asserted-by":"publisher","first-page":"1057685","DOI":"10.3389\/fmed.2023.1057685","volume":"10","author":"A Tamimi","year":"2023","unstructured":"Tamimi A, Sheikhzadeh F, Ezabadi SG, Islampanah M, Parhiz P, Fathabadi A, et al. Post-LASIK dry eye disease: a comprehensive review of management and current treatment options. Front Med. 2023;10:1057685. https:\/\/doi.org\/10.3389\/fmed.2023.1057685.","journal-title":"Front Med"},{"key":"3806_CR54","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.2147\/OPTH.S480704","volume":"18","author":"B Barbosa Ribeiro","year":"2024","unstructured":"Barbosa Ribeiro B, Marques JH, Baptista P, Sousa P, Pires S, Men\u00e9res P, et al. Corneal epithelial thickness correlation with dry eye symptom severity: a cross-sectional study. Clin Ophthalmol. 2024;18:3313\u201320. https:\/\/doi.org\/10.2147\/OPTH.S480704.","journal-title":"Clin Ophthalmol"},{"key":"3806_CR55","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3390\/cells14141086","volume":"14","author":"K Mengrelis","year":"2025","unstructured":"Mengrelis K, Wiletel M, Steiner R, Weijler AM, Wolner L, Stolz V, et al. IL-2 complex therapy mitigates humoral rejection of fully mismatched skin allografts by inhibiting IgG alloantibody formation. Cells. 2025;14:1086. https:\/\/doi.org\/10.3390\/cells14141086.","journal-title":"Cells"},{"key":"3806_CR56","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1080\/14656566.2023.2269090","volume":"24","author":"G Coco","year":"2023","unstructured":"Coco G, Ambrosini G, Poletti S, Meliante LA, Taloni A, Scorcia V, et al. Recent advances in drug treatments for dry eye disease. Expert Opin Pharmacother Taylor Francis. 2023;24:2059\u201379. https:\/\/doi.org\/10.1080\/14656566.2023.2269090.","journal-title":"Expert Opin Pharmacother Taylor Francis"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03806-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03806-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03806-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:03:31Z","timestamp":1779253411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03806-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3806"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03806-w","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments are approved by the Ethics Committee of Peking University People\u2019s Hospital (2025PHE070). Consent to publish is not applicable since no human participant was included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}